Pharma Engineering ApS: Financial statements 2024
CVR: 42133590
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Engineering ApS (CVR 42133590) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 1,475 compared with DKK -4,394 the year before. Equity in the 2024 report amounted to DKK 44,947. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 1,475
- Equity
- DKK 44,947
- Total Assets
- DKK 44,947
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | 1 t. | 45 t. | 0 |
| 2023 | - | 0 | -4 t. | 43 t. | 0 |
| 2022 | - | 0 | 6 t. | 48 t. | 0 |
| 2021 | - | - | 2 t. | 42 t. | 0 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma Engineering ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK -4,394.
About Pharma Engineering ApS
Pharma Engineering ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mads Mose Onsberg. The company is owned by Mads Mose Onsberg. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 6,370 compared with DKK 1,475 the year before. Equity in the 2025 report amounted to DKK 51,317.